Compare Repligen Corporation Common Stock (RGEN) vs Tencent Music Entertainment Group - ADR (TME) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Repligen Corporation Common Stock vs Tencent Music Entertainment Group - ADR — how do they compare? Repligen Corporation Common Stock trades at $178.86 (market cap $11.14B), while Tencent Music Entertainment Group - ADR trades at $8.35 (market cap $13.81B). The key difference: Tencent Music Entertainment Group - ADR is the larger of the two by market cap, and Tencent Music Entertainment Group - ADR pays a 2.82% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Repligen Corporation Common Stock for 0 Days and Tencent Music Entertainment Group - ADR for 68 Days on average.
| RGEN | TME | |
|---|---|---|
Market Cap | $11.14B | $13.81B |
Volume | 1,259,263 | 6,097,902 |
Sector | Health | Media |
52-Week High | $194.57 | $23.71 |
52-Week Low | $102.87 | $7.74 |
Typical Hold Time | 0 Days | 68 Days |
Enterprise Value | $11.02B | $11.76B |
Dividend Yield | — | 2.82% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Tencent Music Entertainment (TME) trades at $8.48, up 0.36% on the day, with a bullish technical signal and strong fundamentals. Revenue grew to $32.9B in 2025, with net income surging to $11.06B, and valuation ratios like a P/E of 9.94 appear attractive. Recent news highlights a $1B notes offering and a $400M share repurchase program, signaling financial discipline.
The outlook is positive with a consensus price target of $12.50, offering 47% upside, but risks include intense competition and regulatory oversight. Earnings have been mixed, with Q2 2026 beating expectations but Q1 and Q4 2025 missing, indicating potential volatility in performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →About Tencent Music Entertainment Group - ADR
TME is the largest online music service provider in China. It was founded in 2016 with the business combination of QQ Music (founded in 2005), Kuwo Music (founded in 2005) and Kugou Music (founded in 2004) streaming platforms. Tencent is the largest shareholder of TME with over 50% shares and over 90% voting rights held. TME also provides social entertainment services, including music live audio/video broadcasts and online concert services through the three platforms mentioned above, and online karaoke through an independent platform WeSing.
Read more on TME →
